Adrx, Inc
Preclinical biotechnology company leveraging proprietary structure-based technology to develop small molecule disaggregators and inhibitors targeting previously undruggable misfolded proteins in neurodegenerative diseases. Our pipeline consists of tau, TDP-43 and alpha-synuclein programs.
7-day free trial · no credit card
Verified contacts
10
available on Kipplo
LinkedIn employees
10
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
1
tools in use
Monthly traffic
32
organic / mo
Sign up free to see all 10 verified contacts at Adrx, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
10 contacts with verified email or phone · masked until revealed.
- AR
Anna Rose Lay
Research Scientist · Science
EmailPhone - BH
Benjamin Harlan
Research Scientist · Science
EmailPhone - JT
James Treanor
Advisor · Science
EmailPhone - JB
Jeannette Bowler
Research Scientist · Science
EmailPhone - MS
Matthew Schultze
Research Associate · Science
EmailPhone - RP
Ramya Parasuram
Scientist Ii · Research & Development
EmailPhone - SG
Sarah Griner
Research Scientist Ii · Science
EmailPhone - AL
Albert Lim
Scientist · Science
EmailPhone - XZ
Xuemei Zhang
Scientist · Science
EmailPhone
Showing 9 of 10 verified contacts
Top roles at Adrx, Inc
7 distinct titles indexed · top 7 shown.
- 3research scientist
- 2scientist
- 1advisor
- 1research associate
- 1research scientist ii
- 1scientist ii
- 1structured finance specialist
Sign up to unlock all 10 contacts at Adrx, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 10 verified contacts at Adrx, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.